ABSTRACT
Nitrobenzene is a rarely encountered poison in clinical practice. Methemoglobinemia associated with the poisoning can be fatal. Early identification of methemoglobinemia and treatment with methylene blue and supportive measures can prevent mortality. However, hemolysis can be an outcome of treatment with methylene blue. Here, we report the case of nitrobenzene poisoning in a 35-year-old male which was treated successfully.
ABSTRACT
A 59-year-old male exhibited anemia for evaluation. Endoscopy was diagnostic of gastric antral vascular ectasia. He was given a trial of thalidomide after informing about the adverse effects. After starting thalidomide at 100 mg/day, his hemoglobin (Hb) improved. Post 1 month of therapy his Hb normalized, but he developed xerosis. He was given symptomatic treatment, but did not improve. Thalidomide was suspected to cause xerosis, it was discontinued for a month and post-discontinuation of drug he is symptom free for past 8 months. This paper reports a rare case of thalidomide induced xerosis with dermatological and neurological involvement.